Price $160.58 |
Market Cap
6.92B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
120.7
|
P/B
6.51
|
P/S
6.94
|
Dividend %
-
|
|
P/CF
14.6
|
P/FCF
32.4
|
Op. Cash Flow
242.3K
|
FCF
4.8
|
|
Op. Margin
8.00%
|
Net Margin
6.00%
|
ROE
6.00%
|
ROI
2.70%
|
|
ROA
3.20%
|
EPS Growth
18.90%
|
Current Ratio
3.0
|
Debt/Equity
48.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc (CDTX) | $2.13 | - | - | 107.4M | Strong Buy |
| Recro Pharma Inc (REPH) | $2.24 | - | - | 114M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $25.31 | - | - | 1.1B | Strong Buy |
| Sensus Healthcare Inc (SRTS) | $3.51 | - | - | 60.2M | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.90 | - | - | 709M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
